Carlo Ballatore

7.1k total citations · 3 hit papers
77 papers, 5.5k citations indexed

About

Carlo Ballatore is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Carlo Ballatore has authored 77 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Physiology, 27 papers in Molecular Biology and 26 papers in Organic Chemistry. Recurrent topics in Carlo Ballatore's work include Alzheimer's disease research and treatments (29 papers), Computational Drug Discovery Methods (13 papers) and Microtubule and mitosis dynamics (12 papers). Carlo Ballatore is often cited by papers focused on Alzheimer's disease research and treatments (29 papers), Computational Drug Discovery Methods (13 papers) and Microtubule and mitosis dynamics (12 papers). Carlo Ballatore collaborates with scholars based in United States, United Kingdom and Belgium. Carlo Ballatore's co-authors include John Q. Trojanowski, Virginia M.‐Y. Lee, Amos B. Smith, Kurt R. Brunden, Donna M. Huryn, Yuemang Yao, Michael J. James, Alex Crowe, Anne‐Marie L. Hogan and Justin S. Potuzak and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Carlo Ballatore

77 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

2007 1.7k citations Carlo Ballatore, Virginia M.‐Y. Lee et al. profile →
Carboxylic Acid (Bio)Isosteres in Drug Design

2013 409 citations Carlo Ballatore, Amos B. Smith et al. ChemMedChem profile →
Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay

2022 151 citations Carmine Varricchio, Carlo Ballatore et al. profile →

Peers

Countries citing papers authored by Carlo Ballatore

Since Specialization

Citations

This map shows the geographic impact of Carlo Ballatore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Ballatore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Ballatore more than expected).

Fields of papers citing papers by Carlo Ballatore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Ballatore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Ballatore. The network helps show where Carlo Ballatore may publish in the future.

Co-authorship network of co-authors of Carlo Ballatore

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Ballatore. A scholar is included among the top collaborators of Carlo Ballatore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Ballatore. Carlo Ballatore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Kaempferia parviflora extract and its methoxyflavones as potential anti-Alzheimer assessing in vitro, integrated computational approach, and in vivo impact on behaviour in scopolamine-induced amnesic mice 2025 ·PLoS ONE ·(unknown), (unknown), Chavi Yenjai, Jinda Wangboonskul, (unknown), (unknown), Carlo Ballatore, Chantana Boonyarat	2
2	d₄-Cystamine: A Deuterated Cystamine Derivative with Improved Anti-Inflammatory and Anti-Fibrotic Activities in a Murine Model of Fibrosing Steatohepatitis 2025 ·ACS Pharmacology & Translational Science ·Aleksandra Leszczynska, (unknown), Benedikt Kaufmann, (unknown), (unknown), (unknown), (unknown), Sun H. Kim, (unknown), Killian Oukoloff, Ludovica Monti, (unknown), Ilya Gertsman, Jeremiah D. Momper, Phillipp Hartmann, Ariel E. Feldstein, Ranjan Dohil, Carlo Ballatore	1
3	Design, Synthesis, and Evaluation of An Anti‐trypanosomal [1,2,4]Triazolo[1,5‐a]pyrimidine Probe for Photoaffinity Labeling Studies 2024 ·ChemMedChem ·(unknown), Karol R. Francisco, Carmine Varricchio, (unknown), Yuemang Yao, Andrea Brancale, Kurt R. Brunden, Conor R. Caffrey, Carlo Ballatore	2
4	Clickable Probes for Pathogen Proteasomes: Synthesis and Applications 2024 ·ACS Omega ·(unknown), (unknown), (unknown), Karol R. Francisco, (unknown), (unknown), Carlo Ballatore, Samuel A. Myers, Anthony J. O’Donoghue, Conor R. Caffrey	1
5	A small‐molecule microtubule‐stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's disease 2024 ·Alzheimer s & Dementia ·Yuemang Yao, (unknown), (unknown), Bin Zhang, (unknown), (unknown), (unknown), (unknown), David J. Gonzalez, Virginia M.‐Y. Lee, Carlo Ballatore, Kurt R. Brunden	6
6	Structure‐Activity Relationships, Tolerability and Efficacy of Microtubule‐Active 1,2,4‐Triazolo[1,5‐ a ]pyrimidines as Potential Candidates to Treat Human African Trypanosomiasis** 2023 ·ChemMedChem ·Ludovica Monti, (unknown), Carmine Varricchio, (unknown), (unknown), Wenqian Yang, Ido Ben‐Shalom, Michael K. Gilson, Kurt R. Brunden, Andrea Brancale, Conor R. Caffrey, Carlo Ballatore	4
7	Inhibition of the HEG1–KRIT1 interaction increases KLF4 and KLF2 expression in endothelial cells 2021 ·FASEB BioAdvances ·Miguel Alejandro Lopez‐Ramirez, Sara McCurdy, Wenqing Li, Mark K. Haynes, (unknown), Karol R. Francisco, Killian Oukoloff, (unknown), (unknown), Hao Sun, Brendan Gongol, (unknown), Carlo Ballatore, Larry A. Sklar, Alexandre R. Gingras	10
8	Evaluation of log P, pKa, and log D predictions from the SAMPL7 blind challenge 2021 ·Journal of Computer-Aided Molecular Design ·(unknown), (unknown), Yingying Zhang, Junjun Mao, M. R. Gunner, Karol R. Francisco, Carlo Ballatore, Stefan M. Kast, David L. Mobley	64
9	Rational design, synthesis, and evaluation of uncharged, “smart” bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase 2020 ·Journal of Biological Chemistry ·Lukáš Górecki, Oksana Gerlits, (unknown), Xiaolin Cheng, Donald Blumenthal, Palmer Taylor, Carlo Ballatore, Andrey Kovalevsky, Zoran Radić	30
10	A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model 2018 ·Molecular Neurodegeneration ·Bin Zhang, Yuemang Yao, Anne‐Sophie Cornec, Killian Oukoloff, Michael J. James, Pyry Koivula, John Q. Trojanowski, Amos B. Smith, Virginia M.‐Y. Lee, Carlo Ballatore, Kurt R. Brunden	32
11	Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs 2016 ·Neurobiology of Disease ·Kurt R. Brunden, Virginia M.‐Y. Lee, Amos B. Smith, John Q. Trojanowski, Carlo Ballatore	80
12	Aβ-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone D 2016 ·Neuropharmacology ·(unknown), Christian Tackenberg, Adnan Ghori, (unknown), (unknown), (unknown), Carlo Ballatore, Amos B. Smith, Lidia Bakota, Roland Brandt	40
13	Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy 2016 ·Acta Neuropathologica Communications ·Vishruti Makani, Bin Zhang, (unknown), Yuemang Yao, Pierrik Lassalas, Kevin Lou, Ian Paterson, Virginia M.‐Y. Lee, John Q. Trojanowski, Carlo Ballatore, Amos B. Smith, Kurt R. Brunden	44
14	Pharmacokinetic, pharmacodynamic and metabolic characterization of a brain retentive microtubule (MT)-stabilizing triazolopyrimidine 2015 ·Bioorganic & Medicinal Chemistry Letters ·Anne‐Sophie Cornec, Michael J. James, Jane Kovalevich, John Q. Trojanowski, Virginia M.‐Y. Lee, Amos B. Smith, Carlo Ballatore, Kurt R. Brunden	28
15	Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease 2014 ·Bioorganic & Medicinal Chemistry ·Kurt R. Brunden, John Q. Trojanowski, Amos B. Smith, Virginia M.‐Y. Lee, Carlo Ballatore	80
16	Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation 2013 ·Journal of Biological Chemistry ·Alex Crowe, Michael J. James, Virginia M.‐Y. Lee, Amos B. Smith, John Q. Trojanowski, Carlo Ballatore, Kurt R. Brunden	116
17	Solid phase synthesis of 2-aminobenzothiazoles 2009 ·Bioorganic & Medicinal Chemistry Letters ·Francesco Piscitelli, Carlo Ballatore, Amos B. Smith	42
18	Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors 2009 ·Experimental Neurology ·Kurt R. Brunden, Carlo Ballatore, Alex Crowe, Amos B. Smith, Virginia M.‐Y. Lee, John Q. Trojanowski	82
19	Kinase-mediated trapping of bi-functional conjugates of paclitaxel or vinblastine with thymidine in cancer cells 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Carlo Ballatore, (unknown), Joel Desharnais, (unknown), Philip Goelet, Zijian Guo, Qing Li, David Nelson, Chengzao Sun, Angelo J. Castellino, Michael Newman	16
20	Enhancing the aqueous solubility of d4T-based phosphoramidate prodrugs 2000 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Christopher McGuigan, Carlo Ballatore, Sheila Srinivasan, Erik De Clercq, Jan Balzarini	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact